Five-Factor Score (FFS, 2011 revised)
Estimates 5-year mortality in systemic necrotizing vasculitides (EGPA, PAN, MPA, GPA), relevant to EGPA prognosis in allergy/immunology.
Evidence tier: Validated instrument.
Formula / logic
FFS (2011) = Age >65 (1) + Cardiac insufficiency (1) + Renal insufficiency, creatinine ≥150 µmol/L (1) + GI involvement (1) + ENT manifestations ABSENT (1, EGPA/GPA only). 5-year mortality: FFS 0 → 9%; FFS 1 → 21%; FFS ≥2 → 40%.
Interpretation
The revised FFS applies across PAN, MPA, EGPA, and GPA. In EGPA and GPA, ENT involvement is protective, so its ABSENCE adds a point.
Evidence & citations
Clinician decision support. Verify against the cited source. Not a substitute for clinical judgment. 100% on-device; no patient data is stored or transmitted.